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Background/aim: The objective of this study is to report our experience with surgical revision of dialysis access-induced ischemia
syndrome.
Materials and methods: Between January 2005 and July 2013, 1254 patients underwent arteriovenous fistula operation, and 86 of them
[53 males, mean age: 55 ± 25 (range: 25 to 75) years; 33 females, mean age: 50 ± 20 (range: 30 to 70) years] subsequently developed
steal syndrome. These patients were treated with arterial pressure-controlled polytetrafluoroethylene banding or constriction with
polypropylene suturing technique. Patients were followed in the outpatient clinic at regular intervals.
Results: Symptoms were not relieved during the first 15 days in 4 patients; therefore, reintervention was performed. Thrombosis
occurred in one patient after reintervention. No early or late complications were detected in other patients, and fistulae were suitable
for hemodialysis. Patency rates at 6 and 12 months were 96% and 92%, respectively, and thrombosis rates were 7% and 9%. There was
no hospital mortality in our study, but one patient died from unrelated causes and two other patients quit follow-up after 6 months.
Conclusion: We think that arterial pressure-controlled surgical revision is an effective and safe technique in patients with fistula-related
hand ischemia.
Key words: Hemodialysis, arteriovenous fistula, hand ischemia, banding technique

1. Introduction
A well-functioning vascular access (VA) is a certain
requirement for providing life-sustaining hemodialysis
treatment in end-stage renal disease (ESRD) patients
(1). Although autogenous arteriovenous fistula (AVF) is
accepted as the ideal VA and is referred to as a ‘lifeline’, it
is not always easy to construct and AVF creation may cause
complications (2). The most frequent complications of AVF
are aneurysm, failure to maturation, and thrombosis (3).
Among complications of native AVF, symptomatic dialysis
access-induced ischemia syndrome (DAIIS), also known
as steal syndrome, is rarely seen. On the other hand, it is a
serious problem and it may cause some clinical findings like
ischemic neuropathy, resting pain, and ulceration or tissue
necrosis of fingers that may lead to amputation. It can be
seen especially after high volume AVF, and its incidence rate
in native AVF varies between 1% and 10% in the literature
(4). The objective of this retrospective study is to report our
experience with surgical revision of fistulae with DAIIS.
* Correspondence: uhalici2003@yahoo.com
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2. Materials and methods
Between January 2005 and July 2013, 1254 patients with
ESRD underwent arteriovenous fistula operations, and 86
of them [53 males, mean age: 55 ± 25 (range: 25 to 75)
years; 33 females, mean age: 50 ± 20 (range: 30 to 70)
years] subsequently developed DAIIS (steal syndrome)
and were included in this study. Written informed consent
was received from the patients. This study was approved
by the local institutional review board. Seventy of them
had native AVF and 16 of them had AVF with synthetic
polytetrafluoroethylene (PTFE) graft. These patients had
been treated with hemodialysis for about 4 ± 3 years, and
all of them had had prior AVF operations at the wrist and
the elbow. Patients with native AVFs had brachiocephalic
AVF, and other patients had brachioaxillary AVF. DAIIS
can be classified into four stages according to the degree
of severity (Table) (5). According to this classification,
retrograde inflow of blood into the access during diastole
is detected in AVF, but the patients have no complaints
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Table. Classification of DAIIS.
Stage

Findings

Stage 1

Retrograde diastolic flow without complaints; steal phenomenon

Stage 2

Pain on exertion and/or during hemodialysis

Stage 3

Resting pain

Stage 4

Ulceration or necrosis or gangrene

(stage 1) and it does not require intervention (6).
Patients with pain on exercise or during dialysis (stage
2), however, require attention, because of the risk of
deterioration to stage 3 (resting pain) or stage 4 (necrosis)
in their early phases. These patients were diagnosed by
clinical examination and color flow Doppler ultrasound
evaluation. Patients with grade 2, 3, and 4 DAIIS were
operated on. Some clinical findings of our patients with
hand ischemia were pallor and coldness, absence of radial
and ulnar artery pulses, intolerable pain under exertion or
pain during dialysis, resting pain, cyanosis, and ulcerations

a

of digits. The most common complaint of our patients was
pain. The brachial artery and radial artery were cannulated
and arterial pressures were monitored and recorded
during the operation. We used sterile Doppler ultrasound
probe for measurement of AVF flow. Our patients’ fistula
mean flow velocity was 900 ± 100 mL/min. Autogenous
AVFs were treated with arterial pressure-controlled PTFE
banding and synthetic PTFE grafts were treated with
constriction with a polypropylene suturing technique (3
cm distal to AVF anastomoses) (Figures 1 and 2). Our aim
was to constrict the AVF until the radiobrachial index was

b

Figure 1. Polytetrafluoroethylene banding technique.
a

b

Figure 2. Constriction with polypropylene suturing technique.
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0.5 in both techniques and intraoperative measurements
of flow velocities were approximately 400 mL/min and
600 mL/min in native fistulae and synthetic PTFE grafts,
respectively.
Patients were followed in the outpatient clinic at regular
intervals. Patients were seen in the outpatient
clinic at 1, 3, 6, and 12 months after the surgery. Color flow
Doppler ultrasound evaluation was performed and flow
velocities were measured for all patients. AVF patency and
symptoms of patients were recorded.
3. Results
The most common risk factors of our patients were
diabetes mellitus (DM) and peripheral arterial occlusive
disease (PAOD). DM was detected in 22 patients (25.5%)
and PAOD was detected in 10 patients (11.6%). In our
study group, 21 patients (24.4%) had pallor and cold
hands (stage 1), but they had no complaints. Sixty patients
(69.8%) had intolerable pain under exertion or pain during
dialysis treatments and impalpable pulses (stage 2), while
4 (4.7%) patients had resting pain (stage 3) and 1 patient
(1.1%) had cyanosis of digits and ulcerations (stage 4).
Symptoms and findings were improved partially or
completely by the banding or constriction procedures in
all patients. Cyanosis of fingers regressed, finger ulcers
were healed partially, and resting and exertion pain
subsided. However, complete remission of symptoms were
not observed in 4 patients (4.7%) for the first 15 days and
in 6 patients (7%) for the first month. Reintervention was
performed due to thrombosis. Thrombosis reoccurred in
one patient after reintervention. AVF thrombectomy was
performed successfully again and the AVF was saved.
Patency rates at 6 and 12 months were 96% and 92%,
respectively, and thrombosis rates were 7% (6 patients) and
9% (8 patients). Rate of remission of ischemic symptoms at
12 months was 98.72%. Limb salvage rate at 12 months was
100%. There was no hospital mortality in our study, but
one patient died from unrelated causes and two patients
quit follow-up after 6 months.
4. Discussion
AVF is a surgically created connection between an
artery and vein in patients with end-stage renal failure.
The native AVF is the optimum option for hemodialysis
patients, as it is associated with lower complication
rates compared to other forms of hemodialysis accesses
(7). AVFs might have hemodynamic complications, which
may lead to neurological or ischemic problems. The
pathophysiologic mechanisms of DAIIS are complex and
poorly understood. Shunting of blood away from highresistance arm and forearm arteries to a low-resistance
area in arteriovenous access, resulting in hypoperfusion
distal to the anastomosis, has been generally assumed to
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be the reason. Furthermore, presence of arterial stenosis
beyond the AVF anastomosis may also play a critical role
in the etiology (8). Ischemic neuropathy can be seen due
to damage to peripheral nerves because of compromised
blood supply. Treatment should be started with a detailed
history and physical examination to rule out nonischemic
causes of hand pain of patients with AVF. Advanced age,
diabetes, female sex, PAOD, large conduits such as femoral
or popliteal veins, and history of multiple prior procedures
increase the risk of steal syndrome in upper extremities
(9). In our study, the most common risk factors of our
patients were DM and PAOD, whereas DAIIS was found
to be more common in males than females.
The incidence rate of DAIIS requiring an intervention
was 6% in our study, which was detected between the
1st and 4th weeks after creation of an AVF. The ideal
treatment option for DAIIS must reverse the ischemia
while preserving the access; however, there was no ideal
treatment for this purpose (10). Stolic et al. (11) reported
in their study that they monitored patients with mild
DAIIS and a radical approach is not required in these
patients. They pointed out that the strategic application
of a treatment depends on the severity of symptoms and
comorbidities of the patients and the skill of the surgical
team (11). We followed the grade 1 patients and did not
perform any operations for those patients. We operated on
patients with grade 2, 3, and 4 DAIIS.
Catheter-based interventions to repair arterial stenoses,
ligation of the access, banding, distal revascularizationinterval ligation, revision using distal inflow, and
proximal arterial inflow procedures, among others, can
be performed for the treatment of symptomatic patients
with DAIIS (12). Recently, some investigators have applied
percutaneous transluminal angioplasty to treat arterial
stenosis with the resolution of hand ischemia and healing
of digital ulcers (13). Percutaneous interventions such
as intravascular coil insertion, percutaneous balloon
angioplasty, and intravascular stent insertion can also be
performed to ameliorate DAIIS (8).
Closure of an AVF (ligation) is another option that
is chosen by some. Although this intervention improves
peripheral circulation immediately and symptoms are
relieved, the surgeon has to find a new suitable artery
and vein to create a new AVF after closure of the old
one. Furthermore, the new fistula needs time to mature,
so a hemodialysis catheter is inserted into another vein
to ensure hemodialysis during this period. Again, there
is a risk of developing ischemia in the new AVF. On
the other hand, ligation of the access limits the patient’s
long-term access options. Therefore, correction of DAIIS
must preserve the access and, at the same time, improve
peripheral arterial circulation (14).
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Based on reports about unsatisfactory improvement
of DAIIS and high rates of AVF thrombosis, the banding
technique was not recommended in some studies (15,16).
Additionally, there are reports that DAIIS healed in 90%
to 100% of patients, while only 10% to 40% of the banded
accesses remained patent in some studies (16–18). Mickley
(14) reported that low fistula flow rate caused by banding
may result in inefficient dialysis therapy or even access
thrombosis while DAIIS syndrome disappears. On the
other hand, Van Hoek et al. (19) reported that ischemic
symptoms attenuated and all patients successfully
continued their dialysis therapy after banding of
hemodialysis access to treat hand ischemia. Hastaoğlu et al.
(20) reported in their study that the continuity of dialysis
can be highly sustained in patients with steal syndrome
due to dialysis, maintaining the current arteriovenous
fistulae through appropriate revision techniques. Özbek
et al. (21) reported that controlled banding with brachial
and radial artery pressure monitoring reduces the risk of
fistula thrombosis and reinterventions (21). In that study,
patency and thrombosis rates at 12 months were 90% and
10%, respectively, and the rate of relief of symptoms was
95%. Likewise, in our study, patency rates at 6 months and
12 months were 96% and 92%, respectively. On the other
hand, thrombosis rates at 6 months and 12 months were

7% and 9%, respectively. Moreover, ischemic symptoms
disappeared completely in 89% of our patients.
The access banding technique aims to create a narrow
vessel segment within the access or reduce flow through
the anastomosis. Native fistulae can be banded by
nonabsorbable sutures, small caliber interposition grafts,
or by narrowing the vein with a tight Dacron or PTFE cuff
(14). In prosthetic accesses, interposition of a short tapered
graft segment has also been suggested in the literature
(16–18,22,23). An accurate physical examination of the
AVF is essential for early diagnosis and timely referral
of the patient is necessary to prevent complications (1).
We used arterial pressure-controlled PTFE banding and
constriction with polypropylene suturing techniques in
our patients, in parallel with the literature findings. We are
of the opinion that synthetic PTFE graft binding method
has more favorable results than the polypropylene suturing
method. However, the patient’s vascular structure has an
important role.
In conclusion, we think that arterial pressurecontrolled surgical revision is an effective and safe
technique in patients with arteriovenous fistula-related
hand ischemia. This technique also has the advantage of
saving veins, which, of course, is worthwhile in patients
under hemodialysis treatment.
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